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c-Rel and p65 trans-activate the monocyte chemoattractant exemplified by glomerulonephritis in which the all-too-
protein-1 gene in interleukin-1 stimulated mesangial cells. frequent failure to resolve the inflammation culminates
Background. The chemokine monocyte chemoattractant pro- in glomerulosclerosis and renal failure [2–4].tein-1 (MCP-1) is secreted by human glomerular mesangial
One chemokine, the monocyte chemoattractant pro-cells in response to interleukin-1 (IL-1) and has a central role
tein-1 (MCP-1), has been shown to mediate recruitmentin amplifying the inflammatory response during glomerulo-
nephritis. However, the mechanism by which IL-1 regulates of monocytes to the inflamed site [1, 5, 6]. In situ hybrid-
its transcription is not understood. Specific members of the ization analysis of renal biopsies has demonstrated acti-
nuclear factor kB/rel (NF-kB) proteins may regulate MCP-1 vated levels of chemokine expression in a number of in-expression in a stimulus- and tissue-specific manner.
flammatory nephropathies (abstract; Cockwell et al, J AmMethods. Electrophoretic mobility shift assays and Western
Soc Nephrol 7:1694, 1996) [5, 6] and a rodent model ofblot analysis characterized the members of the NF-kB family that
bound the two NF-kB sites of the MCP-1 enhancer (A1 and A2) glomerulonephritis showed a significant reduction in glo-
in vitro. Trans-activation of the MCP-1 gene was investigated by merular monocyte/macrophage infiltration following ad-
transfer of the MCP-1 enhancer DNA to mesangial cells. ministration of a neutralizing anti–MCP-1 antiserum [5].Results. Primary human mesangial cells contained in addi-
The glomerular mesangial cell actively participates intion to p50 (NF-kB1) and p65 (Rel A) NF-kB proteins, the
the inflammatory response to glomerular injury [2–4].oncoprotein c-rel, and Rel B, but not p52 (NF-kB2). IL-1 induced
c-rel to form a complex with p65, which bound the MCP-1 A2 In the inflamed glomerulus, it is activated by interleukin-1
site but not the A1 or IL-6 NF-kB sites in vitro. IL-1 up-regulated (IL-1) to proliferate, secrete extracellular matrix, and
transfected MCP-1 enhancer activity. Cotransfer of the MCP-1 synthesize MCP-1 [7], the neutrophil chemoattractantenhancer together with individual members of the NF-kB fam-
IL-8 [8, 9] and the cytokine IL-6 [9].ily showed that the heterodimer c-relp65 or (p65)2 can selec-
The molecular mechanism by which IL-1 regulates thetively trans-activate the MCP-1 gene via its A1 and A2 sites
in mesangial cells. expression of inflammatory genes is poorly understood
Conclusions. This study demonstrates for the first time that [10]. The cytokine induces a spectrum of cell-type–specific
the c-rel oncoprotein can enhance MCP-1 transcription in mes- genes that is responsible for the pleiotropic effects of IL-1.angial cells and suggests that it may have an important role in
However, the ability of these IL-1–induced signaling path-amplifying gene expression in the inflamed glomerulus.
ways to regulate gene transcription selectively or coopera-
tively in a cell- or gene-specific manner remains unclear.
A crucial regulator of many IL-1–responsive genes is
the nuclear factor (NF) kB or rel family of transcriptionChemokines are critical to the establishment of chronic
factors [11, 12]. These proteins have two regulatory sitesinflammatory diseases such as glomerulonephritis [1].
(A1 and A2) in the enhancer region (22640 to 22632Persistent chemokine secretion leads to inflammatory
and 22612 to 22603, respectively) and one in the pro-tissue damage, scarring, and loss of tissue function, as
moter region (290 to 280) of the MCP-1 gene [13, 14].
The enhancer sites A1 and A2 are vital regulatory ele-
ments in the inducible transcription of the gene, and theKey words: primary cells, MCP-1 gene, nuclear factor-kB, interleu-
kin-1, glomerulonephritis. A2 site is critical for IL-1–enhanced MCP-1 activity in
mouse carcinoma cells. In addition, the MCP-1 geneReceived for publication August 4, 1998
encodes regulatory sites for a number of other transcrip-and in revised form February 26, 1999
Accepted for publication April 16, 1999 tion factors, including Sp1, which controls basal tran-
scription [13]. 1999 by the International Society of Nephrology
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The importance of the NF-kB activators of transcrip- METHODS
tion is apparent from the extent to which immune and Materials
inflammatory responses are compromised in mice with Tissue culture medium RPMI 1640 containing stan-
targeted disruption of NF-kB subunits [reviewed in 11, dard supplements (100 U/ml penicillin, 100 mg/ml strep-
12, 15, 16]. In its simplest, most common form, NF-kB tomycin, and 2 mm glutamine) were obtained from
comprises a heterodimer of the most abundant, ubiqui- GIBCO (Uxbridge, UK). Insulin 25 mg/ml, selenium 25
tous members of the family: the 50 (p50/NF-kB1) and mg/ml, transferrin 25 mg/ml, and growth supplement
65 kDa (p65 or RelA) proteins. When inactive, it resides were obtained from Sigma (Dorset, UK), fetal calf serum
as a heterodimer in the cytoplasm of resting cells com- (FCS) from Advance Protein Products Ltd. (West Mid-
plexed to an inhibitory protein I-kBa. After appropriate lands, UK). IL-1a and -b were a gift from Professor Jer-
stimulation of cells, I-kB dissociates from the complex, emy Saklatvala (Kennedy Institute, Charing Cross Hos-
and the active heterodimer translocates to the nucleus pital, London, UK). 3,4-Dichloroisocoumarin (DCI),
to bind its target promoter [11, 12, 17]. IL-1 can rapidly 1-trans-epoxysuccinyl-leucylamide (4-guanidino) butane
induce NF-kB via its type I but not type II receptor [18] (E64), NaF, Na3VO4, b-glycerophosphate, deoxycholate
by phosphorylating and degrading I-kBa/MAD3 [19]. (DOC), Nonidet P40 (NP40), and goat antirabbit peroxi-
Several workers have reported on the importance of I-kB dase-conjugated whole IgG were all supplied by Sigma.
phosphorylation in targeting the inhibitor for ubiquitin- T4 polynucleotide kinase was from Stratagene (Cam-
mediated proteolysis [reviewed in 17]. bridge, UK); [g32P] ATP (6000 Ci/mmol) was from Du-
Recent evidence suggests that specific dimeric combi- Pont NEN (Herts, UK), and poly (dI-dC) was from Phar-
nations of the NF-kB family control the transcription of macia (Milton Keynes, UK). All oligonucleotides were
synthesized and high-performance liquid chromatogra-particular genes. For example, homodimers of p50 and
phy (HPLC) purified by Oswel DNA Service (South-p65 can bind target DNA motifs in lymphoid cells and
ampton, UK). NF-kB p50 antibody was a gift of Dr. H.can repress or activate transcription, respectively [12].
Holmes (MRC AIDS Reagent project, NIBSC, SouthFurthermore, specificity may also be conferred by differ-
Mimms, UK). Antisera to c-rel together with their cog-ential activation of NF-kB proteins in different cell types.
nate peptides were obtained from Serotec (AHP 289;Thus, complexes such as c-rel/p65 can be activated in
Oxford, UK) or Santa Cruz Biotechnology (sc-71x; Hei-monocytes HeLa and THP1 cells [20, 21], but are found
delberg, Germany). The c-rel antisera were each raisedonly in an inactive form in HepG2 cells [22].
against a peptide taken from the C terminus of c-relPrevious studies of MCP-1 transcription in tumor cell
(sequence undisclosed by manufacturer). Antisera to p65lines have shown that lipopolysaccharide, tetradecanoyl
NF-kB (raised against aa 531-550 in C terminus of humanphorbol acetate (TPA), and IL-1 can induce human
p65), Rel B (raised against aa 540-558), its correspondingMCP-1 mRNA synthesis [13, 14, 23]. One previous study
peptide, anti-p52 (aa 298-324) were all supplied by Santahas reported that IL-1b increases MCP-1 mRNA in mes-
Cruz Biotechnology. All tissue culture plastic ware wasangial cells, although only p50 and p65 NF-kB were stud-
purchased from Costar (Bucks, UK).ied and the role of these in trans-activation of the MCP-1
gene in this cell type remains unknown [23]. Interestingly, Cell culture
the mouse homologue of MCP-1, termed JE, appears to
Mesangial cells. Human mesangial cells were preparedbe regulated in a stimulus-specific manner; for example,
by standard methods of serial culture/trypsinization of
regulation by tumor necrosis factor (TNF) appears to adherent outgrowths from glomeruli obtained by sieving
require both distal and proximal NF-kB regions [24], of kidney cortex, and their identity and purity were con-
whereas platelet-derived growth factor (PDGF) invokes firmed as described previously [26, 27]. The normal cor-
an additional remote NF-kB site to activate MCP-1 tran- tex from human kidneys removed from patients with renal
scription [25]. cell carcinoma were used. Cells were cultured in RPMI
This study set out to define the importance of individ- 1640 with 10% FCS supplemented with 1000 U/ml penicil-
ual members of the NF-kB family in regulation of tran- lin, 100 mg/ml streptomycin, 2 mm glutamine, and a growth
scription of the MCP-1 gene in primary mesangial cells, supplement containing 25 mg/ml insulin and transferrin
and to assess whether or not IL-1 enhances MCP-1 gene and 25 mg/ml sodium selenite at 378C in a humidified
expression via selective activation of the NF-kB proteins. 95% air/5% CO2 atmosphere. Cells were used between
The presence of the c-rel oncoprotein is shown, and a passages 3 and 5 after subculture into 162 cm2 flasks.
role for it in binding to the A2 NF-kB site but not to that A clone of mesangial cells isolated from normal rat glo-
of the A1 MCP-1 or the IL-6 promoter is demonstrated. meruli (gift of Dr. Masanori Kitamura, UCL, London,
Moreover, to our knowledge for the first time, IL-1 is UK) was cultured in DMEM/F12/Nut Mix supplied with
shown to up-regulate MCP-1 transcription via both the Glutamax and supplemented with 1000 U/ml penicillin,
A1 and A2 sites in transfected mesangial cells, and a 100 mg/ml streptomycin, and 5% vol/vol FCS. Cells were
used between passages 4 and 18.role for c-rel in MCP-1 trans-activation is demonstrated.
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Preparation of mesangial cells for nuclear factor-jB acti- electrophoresis, gels were dried and then autoradio-
graphed by exposure to medical x-ray film.vation. Confluent mesangial cells were washed twice in
phosphate-buffered saline and placed in growth medium
Supershift analysiscontaining 0.1% FCS for 48 to 72 hours prior to the
Polyclonal antibodies to p50, c-rel, p65, Rel B, or p52experiment. Cell cultures were stimulated with 10 or
were incubated with cell nuclear extracts for either two20 ng/ml IL-1a or IL-1b. At the end of the period of
hours at room temperature or at 48C overnight. Polystimulation, cells were placed on ice and nuclear and
(dI-dC, 3 mg) and 2 ml radiolabeled NF-kB probe werecytosolic extracts were prepared as follows.
then added, and the samples were incubated and electro-Nuclear and cytosolic extract preparation. Cell extracts
phoresed as described for the electrophoretic mobilitywere prepared by modification of previously described
shift assay (EMSA).standard procedures [28, 29]. Protein estimations were
performed by a dye-binding assay [30]. Briefly, cells
Western blot analysiswere washed in ice-cold phosphate-buffered saline and
Cell extracts (100 to 300 mg) were mixed with twice-scraped, on ice, in a hypotonic buffer containing addi-
concentrated sodium dodecyl sulfate-polyacrylamide geltional proteinase and phosphatase inhibitors [buffer A:
electrophoresis (SDS-PAGE) sample buffer, heated10 mm HEPES, pH 7.9, 1.5 mm MgCl2, 10 mm KCl,
(1008C for 3 min), and electrophoresed on gels con-0.5 mm dithiothreitol (DTT), 100 mm phenanthroline,
taining 12.5% acrylamide and 0.33% bis-acrylamide. The1 mg/ml pepstatin, 100 mm E64, 100 mm DCI, 100 mm
gels were electrotransferred to nitrocellulose (250 mANaF, 100 mm Na3VO4, and 25 mm b-glycerophosphate].
for 4 hr) in a buffer containing 25 mm Tris base, 192 mmMesangial cells were then lyzed by incubating for 10
glycine, and 20% methanol (vol/vol). The membraneminutes on ice in 60 to 80 ml hypotonic buffer containing
was incubated for one hour at 378C in blocking buffer0.2% NP40. Lysates were then centrifuged (10,000 g at
[10 mm Tris HCl, pH 7.4, 154 mm NaCl, and 8% (wt/48C) for 10 minutes, and the supernatants were dis-
vol) milk powder], then in blocking buffer supplementedcarded. The pelleted nuclei were resuspended in 60 to
with antiserum (1:500, vol/vol) for 16 hours at 48C. After80 ml of a lysis buffer [buffer C: 20 mm HEPES, pH 7.9,
five washes in Tris-buffered saline (TBS; 10 mm Tris HCl,420 mm NaCl, 1.5 mm MgCl2, 0.2 mm ethylenediamine- pH 7.4, 154 mm NaCl), the membrane was incubated intetraacetic acid (EDTA), 25% glycerol, and 100 mm DCI]
TBS containing an antirabbit peroxidase-conjugated IgGand were incubated at 48C for 15 minutes. Lyzed nuclei
for a further two hours at room temperature, washed aswere vortexed then centrifuged (10,000 g at 48C) for 10
before, and air dried. Proteins were detected by en-minutes, and supernatants were snap frozen and stored
hanced chemiluminescence (ECL; Amersham, Bucking-
at 2808C.
hamshire, UK).
Electrophoretic mobility shift assay Cell transfection and luciferase assays
Nuclear factor-kB binding activity was detected with Rat mesangial cells (50 to 70% confluent) cultured in
synthetic oligonucleotide probes containing either the A1 DMEM/F12/Nut mix containing 0.1% FCS in a 24-well
(22640 to 22632, “TGGGAACTTCC”) or A2 NF-kB plate were transiently transfected with 0.2 mg of pGL3
binding site of the MCP-1 gene (22611 to 22603, “TGG basic plasmid (firefly luciferase reporter vector; Promega,
GAATTTCC”) [13, 14], the NF-kB site of the IL-6 pro- Southampton, UK) containing the MCP-1 enhancer [14]
moter (2125 to 2135, “GGGATTTTCC”) [31], or a per well by incubation with a liposome preparation
consensus mutant site (CTCACTTTCC) [18]. These (Transfast; Promega) for 24 hours at 378C. The effect of
were radiolabeled with [g32P]ATP by T4 polynucleotide individual NF-kB subunits on MCP-1 expression was
kinase for 10 minutes at 378C. investigated by cotransfection of pRSV expression vec-
DNA-binding assays were essentially as previously de- tors (25 ng) containing the cDNAs of p50, p65, or c-rel
scribed [18]. All reactions were performed in a total vol- or the empty expression vector (pRSPA; gifts of Dr.
ume of 20 ml containing the binding buffer [10 mm Tris/ Nancy Rice, NCI, Frederick, MD, USA) as previously
HCl, pH 7.5, 100 mm NaCl, 1 mm EDTA, 4% (vol/vol) described [30]. The cells were then incubated in growth
glycerol, 5 mm DTT, 100 mg/ml bovine serum albumin medium containing 0.1% FCS or IL-1b (20 ng/ml) for
(BSA)], the sample, 2 ml of [32P]-labeled oligonucleotide a further 22 to 24 hours. Transfection efficiency was
and 3 mg of poly (dI-dC). After incubation for 15 minutes determined by cotransfer of 250 pg of a Renilla luciferase
at room temperature, samples were electrophoresed in gene under the control of an SV40 promoter (pRL SV40;
a 5% polyacrylamide gel/0.25 3 Tris borate EDTA, ph Promega). At the end of this period, the Firefly and Renilla
8.0 (TBE). For competition experiments, unlabeled oli- luciferase activities were determined using separate de-
gonucleotides were incubated with extracts for five min- tection buffers consecutively on the same sample ac-
cording to the protocol provided by the manufacturer.utes prior to the addition of radiolabeled probe. After
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Statistical analysis transcription factors. Thus, two IL-1–inducible com-
plexes were detected at consistent levels with both theThe data presented are the mean 6 sem of N experi-
MCP-1 and the IL-6 probes, and a constitutive complexments. Statistical comparisons between multiple groups
was detected only by the A1 and A2 MCP-1 probes.were performed by analysis of variance, with a minimum
value of P , 0.05 considered to represent statistical sig- c-Rel oncoprotein and Rel B are present in
nificance. human mesangial cell extracts
Having established the ability of IL-1a to induce
RESULTS NF-kB activity against the MCP-1 and IL-6 oligonucleo-
tides, it was necessary to identify whether members ofHuman mesangial cells contain
the NF-kB family other than p50 and p65 [23] wereinterleukin-1–inducible NF-kB activity
present in human mesangial cell extracts. Western blotagainst the NF-kB sites of the monocyte
analysis revealed the presence of two of the ubiquitouschemoattractant protein-1 and interleukin-6 promoters
members of the NF-kB family, p50 and p65 (Fig. 2 A,Human mesangial cells are known to secrete MCP-1
B, panels 1–3), in both the nuclear and cytosolic compart-and IL-6 in response to IL-1 [7, 9], but how the cytokine
ments of human mesangial cells. In addition, both cellselectively regulates the expression of inflammatory
fractions contained the oncoprotein c-rel (Fig. 2, panelsgenes is not known. One previous study in human mesan-
4 and 5) and also Rel B (Fig. 2, panels 6 and 7) but notgial cells has reported IL-1–inducible NF-kB activity with
another member of the NF-kB family p52 (NF-kB2; Fig.a tandem repeat of an NF-kB consensus sequence [23].
2B, panel 8). IL-1 consistently increased the level of c-relIn our current study, induction of NF-kB by IL-1a was
in the nucleus, as observed by Western blot analysis ofdemonstrated by employing oligonucleotides containing
nuclear extracts. To confirm the identity of the p65, c-rel,the region of the MCP-1 enhancer that included either
and Rel B antigens, peptides containing the sequences to
the A1 or the A2 NF-kB site (shown to be crucial to
which each antibody was raised were included as compet-
IL-1 activation of the MCP-1 gene in tumor cells) and,
itors in the Western blot analysis (Fig. 2, panels 3, 5, and
for comparison, the NF-kB site from the IL-6 promoter. 7). The p65, c-rel, and Rel B peptides abrogated binding
Confluent cultures were incubated in growth medium of their respective antigens by the antibodies but did not
containing 0.1% vol/vol FCS for 48 to 72 hours and then “cross-compete” with other antibodies (data not shown),
stimulated with 20 ng/ml IL-1a for 1 hour, and nuclear confirming the identity of the proteins detected. The
and cytosolic extracts were prepared as described in minor bands of lower molecular weight detected by the
the Methods section. Oligonucleotides containing the p65 antiserum appear to be specific or immunologically
MCP-1 A1, A2, or IL-6 promoter binding sites for NF-kB related to the antibody, as they were abrogated by pep-
were added to the extracts and NF-kB activity measured tide competition or they may be proteolytic fragments
by EMSA (a minimum of three independent experi- of p65. The specificity of the c-rel antibody was confirmed
ments). Induction of NF-kB activity was observed in by immunoprecipitation of lysates prepared from con-
nuclear extracts following stimulation with IL-1a for 15 fluent rat mesangial cells with 2 different antisera to c-rel
minutes. The A1 and A2 MCP-1 probes detected four (AHP289 c-rel antibody; Serotec) and a C-terminal pep-
DNA–protein complexes (Fig. 1 a–d, lanes 1–4). The tide antibody (sc 71; Santa Cruz Biotechnology), each
two inducible complexes labeled (a) and (b) and the of which detected a protein of approximately 80 kDa,
third complex (c) were also observed with the IL-6 probe further verifying that the antigen detected was c-rel (data
(Fig. 1, lanes 7 and 8), but the fourth constitutive complex not shown).
(d) was not detected. When extracts were mixed with
Interleukin-1 induces c-rel binding to the A2radiolabeled mutant probe, complexes (a), (b), and (d)
but not the A1 or interleukin-6 nuclearwere not observed, indicating that these were NF-kB
factor-kB binding sites in vitrospecific. One nonspecific complex was detected with the
mutant probe (complex c; Fig. 1, lanes 5 and 6). The The level of expression of c-rel and Rel B is tissue
level of binding of complexes (c) and (d) varied between dependent [33–35]. The same antibodies used in the
experiments and is likely to be caused by interdonor Western blot analysis were employed to test the immu-
variation. Incubation of extracts with unlabeled MCP-1 noreactivity of the DNA-protein complexes detected by
A1, A2, or IL-6 probes as competitors abrogated the EMSA. Incubation with antibodies to p50 and p65 re-
formation of (a) and (b) and diminished d (Fig. 1, lanes sulted in either the abrogation of binding or the forma-
9–11). The unlabeled mutant probe did not affect the tion of supershifted complexes, demonstrating that both
binding of any of the specific complexes to the A1 (Fig. proteins were present in the complexes detected by the
1, lane 12) or A2 (Fig. 1, lane 13) probes, confirming A1 and A2 probes (Fig. 3A, B). p50 and p65 appear to
be constituents of the fastest migrating, inducible com-that these consisted of members of the NF-kB family of
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Fig. 1. Interleukin (IL)-1a induces nuclear factor (NF)-kB–specific activity against the monocyte chemoattractant protein-1 (MCP-1) and IL-6
NF-kB sites in human mesangial cells. Nuclear extracts from human mesangial cells incubated with 20 ng/ml IL-1a (IL-1, lanes 2, 4, 6, and 8–13)
or without (C, lanes 1, 3, 5, 7) were incubated with radiolabeled oligonucleotides containing the NF-kB site from the MCP-1 A1 (lanes 1–2, 9,
12), A2, (lanes 3, 4, 10, and 13) or IL-6 (lanes 7, 8, and 11) NF-kB sites and EMSAs performed. The four DNA-protein complexes detected
(arrows a, b, c, d) and the affect of incubation of nuclear extracts with a mutant NF-kB probe (MUT, lanes 5 and 6) or competition with unlabeled
A1 (lane 9), A2 (lane 10), IL-6 (lane 11), or mutant probes on A1 (lane 12) or A2 (lane 13) binding are shown.
plex b, whereas p65 is present in the complexes a and b. 4B, compare lanes 6–10), in agreement with previous
studies [21].Complexes a and b were NF-kB specific (Fig. 1). c-Rel
was found to be present in the complex detected by the
p65c-rel and (p65)2 trans-activate the monocyteA2 (Fig. 3B, lane 7) but not the A1 (Fig. 3A, lane 5)
chemoattractant protein-1 enhancernor the IL-6 probes (Fig. 3C, lane 4). The c-rel antibody
when transfected in mesangial cellsdid not alter the extent of NF-kB binding to the A1 or
the IL-6 probes. Rel B binding was not detected (Fig. 3 To determine whether specific NF-kB subunits inter-
acted with the MCP-1 enhancer, mesangial cells wereA and C, lanes 6 and 5, respectively) and was always
absent from the MCP-1 and IL-6 sites. c-Rel binding to first transfected with the MCP-1 enhancer (0.2 mg) con-
taining the A1 and A2 NF-kB sites. Because of the diffi-the MCP-1 A2 probe was reproducibly detected in seven
experiments, with cells from four donors. Thus, c-rel may culty in transfecting human mesangial cells, primary rat
cells were employed for these experiments. IL-1 up-regu-be involved in regulating the MCP-1 A2, but not the A1
or IL-6 NF-kB, sites in human mesangial cells. To further lated MCP-1 activity in rat mesangial cells, as measured by
an increase in the reporter firefly luciferase activity (Fig. 5).test the validity of the c-rel antibody, supershift assays
were performed on primary human fibroblasts and on IL-1 had no effect on the transfected empty pGL3 basic
vector (data not shown). To study the ability of homodi-HeLa cells. The latter are known to express c-rel. Inter-
estingly, human gingival fibroblasts (HUGI) contained meric and heterodimeric combinations of NF-kB sub-
units to enhance MCP-1 transcription, p50, p65 or c-relp50 and p65 but did not contain c-rel (Fig. 4A, compare
lanes 1–5), whereas the A2 MCP-1 NF-kB complexes in were individually or in heterodimeric combinations, co-
transfected with the MCP-1 enhancer (Fig. 5). In orderHeLa cells appeared to contain active oncoprotein (Fig.
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Fig. 2. Western blot analysis of constituent NF-kB proteins in human mesangial cell extracts. Cytosolic (A) and nuclear extracts (B) were subjected
to SDS-PAGE and electrotransferred to nitrocellulose as described in the Methods section. Membranes were probed with antibodies to NF-kB
p50 (panel 1), p65 (panels 2 and 3), c-rel (panels 4 and 5), Rel B (panels 6 and 7), and p52 (B panel 8). p65, c-rel, and Rel B antibodies were
coincubated with peptides containing the sequences to which each antibody was raised (A and B, panels 3, 5, and 7, respectively). NF-kB antibody
binding was detected with a peroxidase-conjugated IgG followed by enhanced chemiluminescence.
to ensure that identical quantities of DNA were added Mutation of A1 and or A2 nuclear factor-kB sites
abrogates interleukin-1–induced monocyteto the cells in all conditions, empty expression vector
chemoattractant-1 enhancer activitywas added to supplement the level of DNA. All data
were normalized against the level of renilla luciferase To determine which of the NF-kB sites in the MCP-1
activity obtained by cotransfer of pRL SV40 in all condi- enhancer was mediating IL-1a transcriptional activity,
tions. Coexpression of different combinations of the the MCP-1 A1 and A2 sites were mutated individually
NF-kB subunits with the MCP-1 enhancer showed that or in combination, and the effect on enhancer activity
p65-crel and p65 homodimer (but not c-rel homodimer, in mesangial cells transfected with the MCP-1 enhancer
p50p65, nor p50crel) selectively and significantly in- was examined in both the absence (Fig. 6A) or presence
creased MCP-1 transcription. An identical though en- of IL-1 (20 ng/ml, 24 hr) stimulation (Fig. 6B). Mutation
hanced effect was observed following IL-1b (1 ng/ml, 24 of either the A1 or the A2 site or both abrogated MCP-1
enhancer activity in both control and IL-1–stimulatedhr) stimulation.
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Fig. 3. Supershift analysis of human mesangial cell NF-kB complexes detected by the monocyte chemoattractant protein-1 (MCP-1) and interleukin
(IL)-6 probes. Nuclear extracts from human mesangial cells stimulated with 20 ng/ml IL-1a for one hour at 378C (A–C, lanes 1–6, 1–7, and 1–5,
respectively) were preincubated in the absence (lane 1, A–C) or presence (lane 2, A and B) of control serum, an antibody to p50 (A, lane 3; B,
lanes 2 and 3; C lane 2) or p65 (A, lane 4; B, lanes 5 and 6; C, lane 3), c-rel (A, lane 5; B, lane 7; C, lane 4), or Rel B (A, lane 6; C, lane 5)
overnight at 48C at the dilutions shown. EMSAs were performed with the A1 (A), A2 (B), or IL-6 (C) probes prior to autoradiography. Arrows
indicate positions of supershifted complexes.
Fig. 4. Supershift analysis of the NF-kB com-
plexes detected by the monocyte chemoattrac-
tant protein-1 (MCP-1) probe in HUGI and
HeLa cells. Nuclear extracts from HUGI (A,
lanes 1–5) or HeLa cells (B, lanes 6–10) were
stimulated with 20 ng/ml IL-1a for one hour
at 378C (lanes 1–10) and preincubated in the
absence (lanes 1 and 6) or the presence (lanes
2 and 7) of preimmune serum or an antibody
to p50 (lanes 3 and 8), p65 (lanes 4 and 9), or
c-rel (lanes 5 and 10) overnight at 48C. EMSAs
were performed with the MCP-1 probe (A
and B, lanes 1–10) prior to autoradiography.
Arrows indicate positions of supershifted
complexes.
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Fig. 5. Effect of different combinations of
NF-kB subunits on monocyte chemoattrac-
tant protein-1 (MCP-1) transcription in mes-
angial cells before and after stimulation with
IL-1. Cells were transfected with the MCP-1
enhancer (0.2 mg) together with 25 ng of empty
vector pRSP, p50, p65, or c-rel or 25 ng total of
p50p65, p50crel, or p65c-rel. pRL SV40 renilla
luciferase reporter (0.25 ng) was cotransfected
to measure transfection efficiency. Incuba-
tions were performed in medium containing
0.1% fetal calf serum for 24 hours and then
incubated for a further 24 hours in the pres-
ence (j) or absence (h) of IL-1 20 ng/ml.
Turner light units represent firefly luciferase
activity, as measured on a Turner lumino-
meter (normalized against the level of renilla
luciferase activity detected). Results shown
are the means 6 sem of four independent ex-
periments. *P , 0.05.
mesangial cells. It also inhibited the up-regulation of others [36, 37], this was not found in primary human
fibroblasts (HUGI; Fig. 4A). Taken together, these dataMCP-1 enhancer activity observed in the presence of
indicate that in mesangial cells, NF-kB proteins mayc-relp65 or p65 homodimer, indicating that both sites are
regulate the MCP-1 gene in a cell- and/or gene-specificrequired for trans-activation by these NF-kB complexes.
manner.
Recent work in tumor cell lines has shown that two
DISCUSSION NF-kB sites in the MCP-1 enhancer (A1 and A2) are
This study investigated the mechanism by which IL-1 crucial to the induction of MCP-1 transcription [14].
regulates NF-kB–mediated MCP-1 gene expression in Moreover, both p65 homodimers and p65c-rel hetero-
primary mesangial cells. The cytokine is known to acti- dimers overexpressed in mouse embryonic carcinoma
vate the NF-kB family of transcription factors, which cells increased expression of the MCP-1 transcript in
is crucial to the inducible activation of MCP-1 [13], a vivo [14]; however, the relevance of these findings to
chemokine critical to the pathogenesis of glomerulone- mesangial cells has hitherto been unclear. In our current
phritis [1, 5, 6]. study, transfection of a primary clone of mesangial cells
To identify the effects of IL-1 on specific complexes with the MCP-1 enhancer containing both the A1 and
of the NF-kB family, it was necessary first to characterize A2 sites together with different combinations of p50,
the NF-kB proteins that were present and active against p65, or c-rel showed interestingly that the c-relp65 he-
the MCP-1 enhancer in mesangial cells. The experiments terodimer or p65 homodimer selectively up-regulated
also demonstrate that NF-kB subunits can selectively MCP-1 transcription. These are the same complexes that
trans-activate the MCP-1 gene in vivo. We report here were detected by supershift analysis (Fig. 3) as binding
that in addition to p50 and p65, the oncoprotein c-rel the A2 MCP-1 probe in vitro. Transfection experiments
and Rel B are present in primary human mesangial cells. performed with mutant A1 or A2 or both showed the
Studies in mice and transformed cell lines suggest that requirement for both sites in order to obtain maximal in-
the level of expression of c-rel and Rel B is tissue depen- duction of the MCP-1 enhancer both in resting and IL-1–
dent and that they have important cell- and gene-specific stimulated cells. Our inability to detect c-rel binding to
effects [reviewed in 12]. Evidence obtained from our the A1 site in the supershift assay may be due to the
antibody supershift assay experiments shows that c-rel fact that in this assay, the NF-kB sites are isolated and
bound to the A2 MCP-1 but not the A1 or IL-6 NF-kB out of context of the whole enhancer. It may be that
sites, and suggests that c-rel and p65 are constituents of neighboring sequences are important in determining
the same complex bound as a heterodimer to the A2 which proteins bind to these motifs in vivo. Further stud-
MCP-1 region of the enhancer. Although we detected ies on the role of c-rel are underway involving immuno-
depletion of nuclear extracts employing a c-rel antibodyc-rel activity in HeLa cells (Fig. 4B) in agreement with
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The detection of p50 and p65 in the complexes binding
the IL-6 site is in agreement with that reported pre-
viously in U937 cells stimulated with lipopolysaccharide
[38]. Interestingly, a previous study in lymphoid cells has
shown binding of c-rel homodimers to an IL-6 NF-kB site
[39]. Further experiments are required to reveal whether
complex trans-activates the IL-6 gene.
Rel B activity was not detected against either NF-kB
sequence investigated, which is not surprising, as it does
not bind with high affinity to NF-kB sites [12]. Rel B
has been reported to be constitutively active in primary
lymphoid cells of transgenic mice [34], and Rel B knock-
out mice are characterized by multiorgan inflammation
caused by infiltration of mixed populations of inflamma-
tory cells [40]. Rel B can form heterodimers with p50
(NF-kB1), p52 (NF-kB2), and their respective precursors
but not with p65 (Rel A) or c-rel (Rel), suggesting that
it too may be involved in regulating the expression of a
particular subset of genes, which excludes IL-6 and
MCP-1. The inability of Rel B to form homodimers [41]
and the presence of p50 suggest that Rel B might form
heterodimers with p50 in human mesangial cells. The
function of this complex in these cells awaits further
investigation.
Characterization of the NF-kB family in human mes-
angial cells in this study has identified the candidate
proteins that regulate the inducible transcription of
MCP-1 by IL-1. The role of c-rel, in particular, merits
further investigation given its variable level and gene-
specific function in different tissues. Studies of the mech-
anism by which IL-1 exerts its effects on c-rel as well as
on other members of the NF-kB family, for example,
p65, with which it is transcriptionally active, will provide
the basis for defining the events specific to the cytokine
Fig. 6. Effect of mutations of the A1 and or A2 sites in the MCP-1 that regulate chemokine transcription in mesangial cells
enhancer. Cells were transfected with 0.2 mg intact MCP-1 enhancer
and ultimately may identify targets for therapeutic ma-(h), or MCP-1 enhancer with mutated A1 site ( ; MA1), mutated A2
site ( ; MA2), or both ( ; MA1A2) together with 25 ng of empty nipulation of mesangial cell function in the inflamed kid-
vector pRSPA, p50, p65, or c-rel or 25 ng total of p50p65, p50crel, or ney in vivo.
p65c-rel. pRL SV40 renilla luciferase reporter (0.25 ng) was cotrans-
fected to measure transfection efficiency. Incubations were performed
in medium containing 0.1% fetal calf serum for 24 hours and then
incubated for a further 24 hours in the presence (B) or absence (A) of
IL-1 20 ng/ml. Turner light units represent firefly luciferase activity as ACKNOWLEDGMENTS
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